Regulatory Guidelines for Medical Devices in Assisted Reproductive Technology (ART)

“Indirect Tax I Indirect Tax Litigation I Customs & FTP I Central Licensing I Arbitration I Advisory”

Dated: 28.03.2026

Regulatory Guidelines for Medical Devices in Assisted Reproductive Technology (ART)

The Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), has issued a circular addressing the import, manufacturing, sale, and distribution of medical devices intended for Assisted Reproductive Technology (ART) procedures, such as Intrauterine Insemination (IUI) kits and centrifuges for sperm washing. This article aims to provide clarity on the regulatory requirements and emphasize the importance of compliance with the Drugs and Cosmetics Act, 1940, and Medical Devices Rules, 2017.

Regulatory Framework for Medical Devices 

Medical devices in India are governed under the provisions of the Drugs and Cosmetics Act, 1940, and the Medical Devices Rules, 2017. These regulations mandate that all medical devices, except Class A non-sterile and non-measuring devices, require a license for their import, manufacturing, sale, and distribution. This ensures that medical devices meet the necessary safety, quality, and efficacy standards.

Medical Devices Used in Assisted Reproductive Technology 

Medical devices used in ART procedures, such as IUI kits and centrifuges for sperm washing, fall under the definition of medical devices as per the Medical Devices Rules, 2017. These devices play a critical role in procedures aimed at addressing infertility and require stringent oversight to ensure their safety and effectiveness.

Concerns Raised by CDSCO 

The CDSCO has observed instances where firms are selling medical devices intended for ART procedures without obtaining the necessary licenses from the licensing authority. This non-compliance poses risks to public health and undermines the regulatory framework established to ensure the safety and efficacy of medical devices.

Call to Action for Stakeholders 

In light of these concerns, the CDSCO has issued a directive to all stakeholders, including State and Union Territory Drugs Control and Licensing Authorities, as well as Zonal, Sub-Zonal, and Port Offices of CDSCO. Stakeholders are urged to:

Maintain Vigilance: Ensure strict monitoring of the import, manufacturing, distribution, and sale of medical devices used in ART procedures.
Enforce Compliance: Take necessary actions to prevent the sale of unlicensed medical devices and ensure adherence to the Drugs and Cosmetics Act, 1940, and Medical Devices Rules, 2017.
Educate and Inform: Raise awareness among manufacturers, importers, and distributors about the licensing requirements for medical devices used in ART procedures.

Implications of Non-Compliance

Failure to comply with the regulatory requirements can lead to legal consequences, including penalties and restrictions on business operations. More importantly, the use of unlicensed medical devices can compromise patient safety and the success of ART procedures.

Conclusion

The regulation of medical devices used in Assisted Reproductive Technology is crucial to ensure the safety and efficacy of these products. Stakeholders must prioritize compliance with the Drugs and Cosmetics Act, 1940, and Medical Devices Rules, 2017, to uphold the highest standards of healthcare and protect public health. For further information and updates, stakeholders are encouraged to visit the official CDSCO website.

In case you face any issues related to Indirect Tax-Customs, GST, Foreign Trade Policy (FTP), Arbitration matters and Central Licensing and related advisory matters in India then please feel free to get in touch with SJ EXIM Services.

We offer Legal advice and litigation support in matters related to Indirect Tax-Customs, FTP, other Indirect Tax matters & Arbitration law, all sorts of Central licensing and related matters. Come and explore the new way of doing business with us!

Source: CDSCO

Disclaimer

Handy Download:

CDSCO CircularDownload

Connect with us for more-

@ Team S J EXIM SERVICES, New Delhi, IN

CP: Ms. Shubhra Jha, Founder

Tel: +91-11-4999 2707 I +91-9999005693

Web: www.sjexim.services

EMAIL: operations@sjexim.services I shubhra@sjexim.services

Facebook: www.facebook.com/sjeximservices

LinkedIn: https://www.linkedin.com/company/90794255/admin/feed/posts/